BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 22564737)

  • 1. Increased expression of bHLH transcription factor E2A (TCF3) in prostate cancer promotes proliferation and confers resistance to doxorubicin induced apoptosis.
    Patel D; Chaudhary J
    Biochem Biophys Res Commun; 2012 May; 422(1):146-51. PubMed ID: 22564737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of breast cancer growth and initiation by the stem cell-associated transcription factor TCF3.
    Slyper M; Shahar A; Bar-Ziv A; Granit RZ; Hamburger T; Maly B; Peretz T; Ben-Porath I
    Cancer Res; 2012 Nov; 72(21):5613-24. PubMed ID: 23090119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tcf3 and cell cycle factors contribute to butyrate resistance in colorectal cancer cells.
    Chiaro C; Lazarova DL; Bordonaro M
    Biochem Biophys Res Commun; 2012 Nov; 428(1):121-6. PubMed ID: 23063976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer.
    Abkevich V; Timms KM; Hennessy BT; Potter J; Carey MS; Meyer LA; Smith-McCune K; Broaddus R; Lu KH; Chen J; Tran TV; Williams D; Iliev D; Jammulapati S; FitzGerald LM; Krivak T; DeLoia JA; Gutin A; Mills GB; Lanchbury JS
    Br J Cancer; 2012 Nov; 107(10):1776-82. PubMed ID: 23047548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
    Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR
    N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2.
    Greulich H; Kaplan B; Mertins P; Chen TH; Tanaka KE; Yun CH; Zhang X; Lee SH; Cho J; Ambrogio L; Liao R; Imielinski M; Banerji S; Berger AH; Lawrence MS; Zhang J; Pho NH; Walker SR; Winckler W; Getz G; Frank D; Hahn WC; Eck MJ; Mani DR; Jaffe JD; Carr SA; Wong KK; Meyerson M
    Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14476-81. PubMed ID: 22908275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-genome analysis informs breast cancer response to aromatase inhibition.
    Ellis MJ; Ding L; Shen D; Luo J; Suman VJ; Wallis JW; Van Tine BA; Hoog J; Goiffon RJ; Goldstein TC; Ng S; Lin L; Crowder R; Snider J; Ballman K; Weber J; Chen K; Koboldt DC; Kandoth C; Schierding WS; McMichael JF; Miller CA; Lu C; Harris CC; McLellan MD; Wendl MC; DeSchryver K; Allred DC; Esserman L; Unzeitig G; Margenthaler J; Babiera GV; Marcom PK; Guenther JM; Leitch M; Hunt K; Olson J; Tao Y; Maher CA; Fulton LL; Fulton RS; Harrison M; Oberkfell B; Du F; Demeter R; Vickery TL; Elhammali A; Piwnica-Worms H; McDonald S; Watson M; Dooling DJ; Ota D; Chang LW; Bose R; Ley TJ; Piwnica-Worms D; Stuart JM; Wilson RK; Mardis ER
    Nature; 2012 Jun; 486(7403):353-60. PubMed ID: 22722193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cells.
    Cen L; Carlson BL; Schroeder MA; Ostrem JL; Kitange GJ; Mladek AC; Fink SR; Decker PA; Wu W; Kim JS; Waldman T; Jenkins RB; Sarkaria JN
    Neuro Oncol; 2012 Jul; 14(7):870-81. PubMed ID: 22711607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Counteracting effects operating on Src homology 2 domain-containing protein-tyrosine phosphatase 2 (SHP2) function drive selection of the recurrent Y62D and Y63C substitutions in Noonan syndrome.
    Martinelli S; Nardozza AP; Delle Vigne S; Sabetta G; Torreri P; Bocchinfuso G; Flex E; Venanzi S; Palleschi A; Gelb BD; Cesareni G; Stella L; Castagnoli L; Tartaglia M
    J Biol Chem; 2012 Aug; 287(32):27066-77. PubMed ID: 22711529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of MicroRNA-206 in the Regulation of Diabetic Wound Healing via Hypoxia-Inducible Factor 1-Alpha.
    Bai Z; Zhou D; Tao K; Lin F; Wang H; Sun H; Liu R; Li Z
    Biochem Genet; 2024 Mar; ():. PubMed ID: 38446322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exportin XPO7 acts as an oncogenic factor in prostate cancer via upregulation of TCF3.
    Lin Y; Zhan M; Xu B
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7663-7677. PubMed ID: 37000263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional factor 3 binds to sirtuin 1 to activate the Wnt/β-catenin signaling in cervical cancer.
    Yu X; Li Z; Bai R; Tang F
    Bioengineered; 2022 May; 13(5):12516-12531. PubMed ID: 35587604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of TCF3, transcription factor 3, is a defense response against methylmercury toxicity in mouse neuronal C17.2 cells.
    Toyama T; Wang Y; Kim MS; Takahashi T; Naganuma A; Hwang GW
    Toxicol Res; 2021 Oct; 37(4):451-458. PubMed ID: 34631502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEX3D is an oncogenic driver in prostate cancer.
    Shao L; Wang J; Karatas O; Ittmann M
    Prostate; 2021 Nov; 81(15):1202-1213. PubMed ID: 34455614
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Chen J; Xu Y; Hu H; Jin T
    Biomed Res Int; 2021; 2021():6670456. PubMed ID: 33824876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of THBS1 on the Biological Function of Hypertrophic Scar Fibroblasts.
    Jiang D; Guo B; Lin F; Hui Q; Tao K
    Biomed Res Int; 2020; 2020():8605407. PubMed ID: 33376743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription Factors That Govern Development and Disease: An Achilles Heel in Cancer.
    Huilgol D; Venkataramani P; Nandi S; Bhattacharjee S
    Genes (Basel); 2019 Oct; 10(10):. PubMed ID: 31614829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of E2A in mid-secretory endometrium of women suffering from recurrent miscarriage.
    Yin ZN; Ding JL; Zhang Y; Li SJ; Zhang Y; Yang J
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):910-914. PubMed ID: 29270752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNAi-mediated
    Ma J; Wang XB; Li R; Xuan SH; Wang F; Li XH; Zhang ZP; Tan L; Li L
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28864779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-1299 is a negative regulator of STAT3 in colon cancer.
    Wang Y; Lu Z; Wang N; Zhang M; Zeng X; Zhao W
    Oncol Rep; 2017 Jun; 37(6):3227-3234. PubMed ID: 28498395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.